REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
YOKOHAMA, Japan, June 24, 2026 /PRNewswire/ — REPROCELL Inc. today announced the…
Frost & Sullivan: Aileen.ai Receives the 2026 North American Transformational Innovation Leadership Recognition for Advancing Relationship-Based AI-Enabled Senior Care
The company’s innovative AI health companion enhances continuity of care through scalable,…